Ocean Biomedical Statistics
Share Statistics
Ocean Biomedical has 166.01M
shares outstanding. The number of shares has increased by 305.74%
in one year.
| Shares Outstanding | 166.01M |
| Shares Change (YoY) | 305.74% |
| Shares Change (QoQ) | 303.76% |
| Owned by Institutions (%) | 13.38% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 418,772 |
| FTD / Avg. Volume | 0.66% |
Short Selling Information
The latest short interest is 1.66M, so 1% of the outstanding
shares have been sold short.
| Short Interest | 1.66M |
| Short % of Shares Out | 1% |
| Short % of Float | 1.16% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -4.61 and the forward
PE ratio is -0.01.
Ocean Biomedical's PEG ratio is
0.
| PE Ratio | -4.61 |
| Forward PE | -0.01 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | -0.16 |
| P/FCF Ratio | -3.64 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Ocean Biomedical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02,
with a Debt / Equity ratio of -0.17.
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | -0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.9 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-471,571.43 |
| Employee Count | 7 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
